Blood rheology and cognition in the Edinburgh type 2 diabetes study

Age and Ageing

Volumn 39, Issue 3, 2010, Pages 354-359

  Marioni, Riccardo E ^a   Deary, Ian J ^a   Strachan, Mark W ^b   Lowe, Gordon D ^c   Rumley, Ann ^c   Murray, Gordon D ^a   Price, Jackie F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cognition; Rheology; Type 2 diabetes mellitus

Indexed keywords

AGED; ARTICLE; BLOOD RHEOLOGY; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; COGNITION; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; FUNCTION TEST; GLYCEMIC CONTROL; HEMATOCRIT; HUMAN; INTELLIGENCE; LINGUISTICS; MAJOR CLINICAL STUDY; MALE; MENTAL CAPACITY; MENTAL FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA VISCOSITY; PRIORITY JOURNAL; SCORING SYSTEM;

AGE FACTORS; AGED; AGING; BIOLOGICAL MARKERS; BLOOD VISCOSITY; COGNITION; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GERIATRIC ASSESSMENT; HEMATOCRIT; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RHEOLOGY;

EID: 77951894499     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afq021     Document Type: Article

References (26)

1. Lowe GDO. Is sticky blood a treatable determinant of cognitive decline and of dementia? Age Ageing 2001; 30: 101-3.
2. Lowe GDO. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 2006; 133: 232-50
3. Elwood PC, Pickering J, Gallacher JE. Cognitive function and blood rheology: results from the Caerphilly cohort of older men. Age Ageing 2001; 30: 135-9.
4. Marioni RE, Stewart MC, Murray GD et al. Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in non-demented individuals. Psychosom Med 2009; 71: 901-6.
5. Wade JP, Pearson TC, Russell RW, Wetherley-Mein G. Cerebral blood flow and blood viscosity in patients with polycythaemia secondary to hypoxic lung disease. Br Med J (Clin Res Ed) 1981; 283: 689-92.
6. Willison JR, Thomas DJ, du Boulay GH et al. Effect of high haematocrit on alertness. Lancet 1980; 1: 846-8.
7. Price JF, Reynolds RM, Mitchell RJ et al. The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord 2008; 8: 18.
8. Wechsler D. Manual of the Wechsler Memory Scale - Revised. New York: The Psychological Corporation Limited, 1987.
9. Wechsler D. Wechsler Adult Intelligence Scale (UK). 3rd edition London, UK: The Psychological Corporation, 1998.
10. Lezak M. Neuropsychological Assessment. 3rd edition. Oxford: Oxford University Press, 1995.
11. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York: Oxford University Press, 1991.
12. Raven J, Raven JC, Court JH. Manual for Raven's Progressive Matrices and Vocabulary Scales. Oxford, UK: Oxford Psychologists Press, 1998.
13. Zigmond AS, Snaith RP. The hospital anxiety and depression scales. Acta Psychiatr Scand 1983; 67: 361-70.
14. Crawford JR, Deary IJ, Starr J, Whalley LJ. The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval. Psychol Med 2001; 31: 451-8.
15. Deary IJ, Whalley LJ, Crawford JR. An 'instantaneous' estimate of a lifetime's cognitive change. Intelligence 2004; 32: 113-9.
16. . The Scottish Government. Scottish Index of Multiple Deprivation. Available at http://www.scotland.gov.uk/Topics/Statistics/SIMD/BackgroundMethodology (accessed 1 July 2009).
17. Ihaka R, Gentleman R. R. A language for data analysis and graphics. J Comput Graph Stat 1996; 5: 299-314.
18. Luciano M, Marioni RE, Gow AJ, Starr JM, Deary IJ. Reverse causation in the association between C-reactive protein and fibrinogen levels and cognitive abilities in an aging sample. Psychosom Med 2009; 71: 404-9.
19. Strachan MW, Reynolds RM, Frier BM, Mitchell RJ, Price JF. The relationship between type 2 diabetes and dementia. Br Med Bull 2008; 88: 131-46.
20. Tamariz LJ, Young JH, Pankow JS et al. Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 2008; 168: 1153-60.
21. Brun JF, Aloulou I, Varlet-Marie E. Type 2 diabetics with higher plasma viscosity exhibit a higher blood pressure. Clin Hemorheol Microcirc 2004; 30: 365-72.
22. Rafnsson SB, Deary IJ, Smith FB et al. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study. J Am Geriatr Soc 2007; 55: 700-7.
23. van Oijen M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke 2005; 36: 2637-41.
24. Stott DJ, Spilg E, Campbell AM, Rumley A, Mansoor MA, Lowe GD. Haemostasis in ischaemic stroke and vascular dementia. Blood Coagul Fibrinolysis 2001; 12: 651-7.
25. van Oijen M, Cheung EY, Geluk CE et al. Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study. J Neurol Neurosurg Psychiatry 2008; 79: 799-803.
26. Lowe GDO, Rumley A, Norrie J et al. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost 2000; 84: 553-8.